Robert Clancy
Overview
Explore the profile of Robert Clancy including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
48
Citations
1009
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tang W, Khalili L, Gong R, Souvignier M, Wang X, Murray S, et al.
Semin Arthritis Rheum
. 2025 Feb;
71:152661.
PMID: 39985848
Introduction: Joint involvement is present in up to 95 % of patients with SLE. Arthritis is a main cause of work-related disability and 70-80 % of lupus patients in clinical...
2.
Buyon J, Carlucci P, Cuneo B, Masson M, Izmirly P, Sachan N, et al.
Lancet Rheumatol
. 2024 Nov;
7(1):e6-e9.
PMID: 39557050
No abstract available.
3.
Scheim D, Parry P, Rabbolini D, Aldous C, Yagisawa M, Clancy R, et al.
Viruses
. 2024 Apr;
16(4).
PMID: 38675987
Consistent with the biochemistry of coronaviruses as well established over decades, SARS-CoV-2 makes its initial attachment to host cells through the binding of its spike protein (SP) to sialylated glycans...
4.
Horisberger A, Griffith A, Keegan J, Arazi A, Pulford J, Murzin E, et al.
bioRxiv
. 2024 Jan;
PMID: 38293222
Lupus nephritis (LN) is a frequent manifestation of systemic lupus erythematosus, and fewer than half of patients achieve complete renal response with standard immunosuppressants. Identifying non-invasive, blood-based pathologic immune alterations...
5.
Fava A, Buyon J, Magder L, Hodgin J, Rosenberg A, Demeke D, et al.
JCI Insight
. 2024 Jan;
9(2.
PMID: 38258904
Lupus nephritis (LN) is a pathologically heterogenous autoimmune disease linked to end-stage kidney disease and mortality. Better therapeutic strategies are needed as only 30%-40% of patients completely respond to treatment....
6.
Buyon J, Izmirly P, Masson M, Carlucci P, Izmirly C, Clancy R, et al.
Arthritis Rheumatol
. 2024 Jan;
76(6):986-987.
PMID: 38233972
No abstract available.
7.
Firl C, Halushka M, Fraser N, Masson M, Cuneo B, Saxena A, et al.
Front Immunol
. 2023 Apr;
14:1114808.
PMID: 37090702
Background: Fibrosis and dystrophic calcification disrupting conduction tissue architecture are histopathological lesions characterizing cardiac manifestations of neonatal lupus (cardiac-NL) associated with maternal anti-SSA/Ro antibodies. Objectives: Increased appreciation of heterogeneity in...
8.
Cornwell M, El Bannoudi H, Luttrell-Williams E, Engel A, Barrett T, Myndzar K, et al.
J Transl Med
. 2023 Apr;
21(1):247.
PMID: 37029410
Background: The clinical heterogeneity of SLE with its complex pathogenesis remains challenging as we strive to provide optimal management. The contribution of platelets to endovascular homeostasis, inflammation and immune regulation...
9.
El Bannoudi H, Cornwell M, Luttrell-Williams E, Engel A, Rolling C, Barrett T, et al.
Arthritis Rheumatol
. 2022 Oct;
75(5):711-722.
PMID: 36245285
Objective: Platelets are mediators of inflammation with immune effector cell properties and have been implicated in the pathogenesis of systemic lupus erythematosus (SLE). This study investigated the role of platelet-associated...
10.
Reed B, Meyer M, Abramzon V, Ad O, Adcock P, Ahmad F, et al.
Science
. 2022 Oct;
378(6616):186-192.
PMID: 36227977
Studies of the proteome would benefit greatly from methods to directly sequence and digitally quantify proteins and detect posttranslational modifications with single-molecule sensitivity. Here, we demonstrate single-molecule protein sequencing using...